Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. August 2025 05:00 ET | Quelle: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey

Er-Kim signs distribution agreement with CNX Therapeutics to distribute its portfolio of oncology medications across CEE and Turkey.
30. Juni 2025 08:00 ET | Quelle: Er-Kim Pharmaceuticals

Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions

Er-Kim has partnered with Immunocore to bring KIMMTRAK (tebentafusp) to patients in Turkey, MENA, Caucasus, and CIS regions
10. Dezember 2024 07:00 ET | Quelle: Er-Kim

Er-Kim Extends Exclusive Distribution Agreement with Ascendis Pharma A/S to Expand Commercialization of Its Endocrinology Portfolio to Eurasian Markets

Er-Kim broadens drug distribution for novel rare endocrinology disease therapies in CEE and Eurasian markets
15. Oktober 2024 07:00 ET | Quelle: Er-Kim

Er-Kim CEO Cem Zorlular Recognized as a Patient Champion on the 2024 PharmaVoice 100

Cem Zorlular, CEO of Er-Kim recognized as a patient champion in this year's PharmaVoice100